首页 > 最新文献
paperpass

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine最新文献

英文 中文
"The Bitter Truth of Sugar"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series. “糖的苦涩真相”——钠-葡萄糖共转运蛋白-2抑制剂引起的糖尿病酮症酸中毒:一个病例系列。
Mehul Shah, Edwin Pathrose, Nikhil M Bhagwat, David Chandy

Diabetic ketoacidosis (DKA) is an acute and major complication of diabetes mellitus (DM), both type I and type II. Biochemically, DKA consists of a triad of blood sugar levels greater than 250 mg/dL, ketonemia of greater than 3 mmol/L and/or significant ketonuria, and a blood pH less than 7.3 with an increased anion gap. Currently, the sodium-glucose cotransporter-2 inhibitors (SGLT-2i) are widely used in management of type II diabetes. There have been several reports of an association between euglycemic diabetic ketoacidosis (EuDKA) and SGLT-2i agents. We present three different patients who were on SGLT-2i therapy who developed recurrent EuDKA postprocedure or sepsis. We believe that prolonged treatment (5-6 days) with intravenous (IV) insulin with glucose until resolution of glycosuria can be considered as an inexpensive marker of resolution of EuDKA. Moreover, the recommended duration for discontinuation of these drugs prior to elective procedures should be longer than 3 days. How to cite this article: Shah M, Pathrose E, Bhagwat NM, Chandy D. "The Bitter Truth of Sugar"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series. Indian J Crit Care Med 2022;26(1):123-126.

糖尿病酮症酸中毒(DKA)是I型和II型糖尿病(DM)的急性和主要并发症。从生化角度看,DKA包括血糖水平大于250mg /dL,酮血症大于3mmol /L和/或显著的酮尿症,以及阴离子间隙增大的血液pH值小于7.3。目前,钠-葡萄糖共转运蛋白-2抑制剂(SGLT-2i)被广泛应用于II型糖尿病的治疗。已经有几篇关于糖尿病酮症酸中毒(EuDKA)和SGLT-2i药物之间的关联的报道。我们介绍了三名接受SGLT-2i治疗的患者,他们在术后出现复发性EuDKA或败血症。我们认为,长期静脉注射胰岛素加葡萄糖治疗(5-6天),直到糖尿消退,可以被认为是EuDKA消退的廉价标志。此外,在选择性手术之前,建议停药时间应超过3天。如何引用本文:Shah M, Pathrose E, Bhagwat NM, Chandy D。“糖的苦涩真相”——钠-葡萄糖共转运蛋白-2抑制剂引起的糖尿病酮症酸中毒:一个病例系列。中华检验医学杂志;2009;26(1):123-126。
{"title":"\"The Bitter Truth of Sugar\"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series.","authors":"Mehul Shah,&nbsp;Edwin Pathrose,&nbsp;Nikhil M Bhagwat,&nbsp;David Chandy","doi":"10.5005/jp-journals-10071-24076","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24076","url":null,"abstract":"<p><p>Diabetic ketoacidosis (DKA) is an acute and major complication of diabetes mellitus (DM), both type I and type II. Biochemically, DKA consists of a triad of blood sugar levels greater than 250 mg/dL, ketonemia of greater than 3 mmol/L and/or significant ketonuria, and a blood pH less than 7.3 with an increased anion gap. Currently, the sodium-glucose cotransporter-2 inhibitors (SGLT-2i) are widely used in management of type II diabetes. There have been several reports of an association between euglycemic diabetic ketoacidosis (EuDKA) and SGLT-2i agents. We present three different patients who were on SGLT-2i therapy who developed recurrent EuDKA postprocedure or sepsis. We believe that prolonged treatment (5-6 days) with intravenous (IV) insulin with glucose until resolution of glycosuria can be considered as an inexpensive marker of resolution of EuDKA. Moreover, the recommended duration for discontinuation of these drugs prior to elective procedures should be longer than 3 days. <b>How to cite this article:</b> Shah M, Pathrose E, Bhagwat NM, Chandy D. \"The Bitter Truth of Sugar\"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series. Indian J Crit Care Med 2022;26(1):123-126.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"123-126"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/01/ijccm-26-123.PMC8783253.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Aerococcus viridans Bacteremia: A Rare Case Report from India. 绿色气球菌菌血症:印度一例罕见病例报告。
Krithika Varshini, Vithiya Ganesan, Jhansi Charles

Aerococci are fastidious, gram-positive Streptococcus-like organisms widely distributed in the hospital environment. Aerococcus viridans is primarily an opportunistic pathogen. Very few cases of A. viridans bacteremia have been reported so far probably because of its misidentification as streptococci. Here we report an interesting case of A. viridans bacteremia. How to cite this article: Varshini K, Ganesan V, Charles J. Aerococcus viridans Bacteremia: A Rare Case Report from India. Indian J Crit Care Med 2022;26(1):127-128.

航空球菌是一种挑剔的革兰氏阳性链球菌样生物,广泛分布于医院环境中。绿气球菌主要是一种机会致病菌。迄今为止,鲜少报道绿芽胞杆菌菌血症病例,这可能是因为它被误认为是链球菌。在此,我们报告一例有趣的绿芽胞杆菌菌血症。Varshini K, Ganesan V, Charles J.绿光气球菌菌血症:印度一例罕见病例报告。中华检验医学杂志;2009;26(1):127-128。
{"title":"<i>Aerococcus viridans</i> Bacteremia: A Rare Case Report from India.","authors":"Krithika Varshini,&nbsp;Vithiya Ganesan,&nbsp;Jhansi Charles","doi":"10.5005/jp-journals-10071-24072","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24072","url":null,"abstract":"<p><p>Aerococci are fastidious, gram-positive <i>Streptococcus</i>-like organisms widely distributed in the hospital environment. <i>Aerococcus viridans</i> is primarily an opportunistic pathogen. Very few cases of <i>A. viridans</i> bacteremia have been reported so far probably because of its misidentification as streptococci. Here we report an interesting case of <i>A. viridans</i> bacteremia. <b>How to cite this article:</b> Varshini K, Ganesan V, Charles J. <i>Aerococcus viridans</i> Bacteremia: A Rare Case Report from India. Indian J Crit Care Med 2022;26(1):127-128.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"127-128"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/10/ijccm-26-127.PMC8783239.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Severe Rhabdomyolysis and Acute Renal Failure Treated by Continuous Venovenous Hemodiafiltration in a Child with Diabetic Ketoacidosis. 持续静脉-静脉血液滤过治疗1例糖尿病酮症酸中毒患儿的严重横纹肌溶解和急性肾功能衰竭。
Ayhan Yaman

Diabetic ketoacidosis (DKA) is the most serious hyperglycemic emergency in patients with type I diabetes mellitus and is associated with significant morbidity and mortality. DKA may be a life-threatening condition due to severe clinical and biological impairments and treatment-associated complications [cerebral edema, acute respiratory failure, acute renal failure (ARF), hypokalemia, hypophosphatemia]. The development of ARF with rhabdomyolysis is a rare but potentially lethal disorder in children with DKA with an estimated mortality of about 50%. Continuous renal replacement therapy is commonly used in intensive care units to provide renal replacement and fluid management. We successfully treated a 13-year-old boy with continuous venovenous hemodiafiltration, who had been diagnosed with severe DKA, complicated with hypophosphatemia-induced acute respiratory failure, rhabdomyolysis and ARF, persistent acidosis, and coma. How to cite this article: Yaman A. Severe Rhabdomyolysis and Acute Renal Failure Treated by Continuous Venovenous Hemodiafiltration in a Child with Diabetic Ketoacidosis. Indian J Crit Care Med 2022;26(1):136-138.

糖尿病酮症酸中毒(DKA)是I型糖尿病患者中最严重的高血糖急症,具有显著的发病率和死亡率。由于严重的临床和生物学损伤以及治疗相关并发症[脑水肿、急性呼吸衰竭、急性肾功能衰竭(ARF)、低钾血症、低磷血症],DKA可能是一种危及生命的疾病。ARF合并横纹肌溶解是DKA患儿中一种罕见但可能致命的疾病,估计死亡率约为50%。持续肾脏替代疗法通常用于重症监护病房,以提供肾脏替代和液体管理。我们成功治疗了一名13岁的男孩,他被诊断为严重的DKA,并发低磷血症引起的急性呼吸衰竭,横纹肌溶解和ARF,持续酸中毒和昏迷。Yaman a .持续静脉-静脉血液滤过治疗糖尿病酮症酸中毒儿童的严重横纹肌溶解和急性肾功能衰竭。中华检验医学杂志,2014;26(1):136-138。
{"title":"Severe Rhabdomyolysis and Acute Renal Failure Treated by Continuous Venovenous Hemodiafiltration in a Child with Diabetic Ketoacidosis.","authors":"Ayhan Yaman","doi":"10.5005/jp-journals-10071-24093","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24093","url":null,"abstract":"<p><p>Diabetic ketoacidosis (DKA) is the most serious hyperglycemic emergency in patients with type I diabetes mellitus and is associated with significant morbidity and mortality. DKA may be a life-threatening condition due to severe clinical and biological impairments and treatment-associated complications [cerebral edema, acute respiratory failure, acute renal failure (ARF), hypokalemia, hypophosphatemia]. The development of ARF with rhabdomyolysis is a rare but potentially lethal disorder in children with DKA with an estimated mortality of about 50%. Continuous renal replacement therapy is commonly used in intensive care units to provide renal replacement and fluid management. We successfully treated a 13-year-old boy with continuous venovenous hemodiafiltration, who had been diagnosed with severe DKA, complicated with hypophosphatemia-induced acute respiratory failure, rhabdomyolysis and ARF, persistent acidosis, and coma. <b>How to cite this article:</b> Yaman A. Severe Rhabdomyolysis and Acute Renal Failure Treated by Continuous Venovenous Hemodiafiltration in a Child with Diabetic Ketoacidosis. Indian J Crit Care Med 2022;26(1):136-138.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"136-138"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/71/ijccm-26-136.PMC8783252.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Assessment of Risk Factors for Coronavirus Disease-2019 in Healthcare Workers: A Case-Control Study. 医护人员冠状病毒病-2019危险因素评估:病例-对照研究
Sukhyanti Kerai, Rahil Singh, Kirti N Saxena, Suraj D Desai

Background and aims: With the rise of coronavirus disease-2019 (COVID-19) cases globally, the infection among frontline healthcare workers (HCWs) escalates many folds. There is, however, limited literature from low middle-income countries regarding risk factors for COVID-19 infection in HCWs. We conducted a case-control study to evaluate the risk factors of COVID-19 infection to HCWs.

Materials and methods: This case-control study was conducted in a designated COVID-19 hospital. Eighty-one HCWs involved in direct care of COVID-19 patients, identified as cases, and 266 were recruited as controls. Telephonic interviews with participants were conducted, and information regarding demographic variables, chemoprophylaxis, exposure to infected patients, and adherence to infection prevention and control (IPC) measures was collected.

Results: We observed a statistically significant difference in the number of times training session for IPC measures attended by HCWs (p = 0.02), performance of aerosol-generating medical procedures (AGMPs) (p <0.001), practices of donning and doffing of personal protective equipment (PPE) (p <0.001), hand hygiene (p <0.001), and decontamination of highly touched surfaces (p <0.001). Logistic regression analysis revealed if the decontamination of highly touched surfaces is decreased by one unit, the odds of getting COVID-19 infection is multiplied by a factor of 0.41 and AGMPs decrease the risk of being a case by 0.76.

Conclusion: This study highlighted that inadequate observation of IPC methods increases the risk of COVID-19 infection to frontline HCWs, whereas performance of AGMPs does not enhance the risk. In this study, HCWs undertaking an AGMP, because of concern of acquiring infection, were more diligent during procedures and hence had lesser infection.

How to cite this article: Kerai S, Singh R, Saxena KN, Desai SD. Assessment of Risk Factors for Coronavirus Disease-2019 in Healthcare Workers: A Case-Control Study. Indian J Crit Care Med 2022;26(1):76-84.

背景与目的:随着2019冠状病毒病(COVID-19)病例在全球范围内的上升,一线医护人员(HCWs)的感染增加了许多倍。然而,低收入中等收入国家关于卫生保健工作者感染COVID-19的危险因素的文献有限。我们通过病例对照研究评估医护人员感染COVID-19的危险因素。材料和方法:本病例-对照研究在新冠肺炎定点医院进行。81名直接护理COVID-19患者的医护人员被确定为病例,266名被招募为对照组。对参与者进行了电话访谈,并收集了有关人口统计学变量、化学预防、接触感染患者以及遵守感染预防和控制(IPC)措施的信息。结果:我们观察到医护人员参加IPC措施培训的次数(p = 0.02)和产生气溶胶的医疗程序(agmp)的表现(p p p p)有统计学意义差异。结论:本研究强调,对IPC方法的观察不足会增加一线医护人员感染COVID-19的风险,而agmp的表现不会增加风险。在本研究中,进行AGMP的医护人员由于担心感染,在操作过程中更加勤奋,因此感染较少。本文摘自:Kerai S, Singh R, Saxena KN, Desai SD。医护人员冠状病毒病-2019危险因素评估:病例-对照研究中华检验医学杂志;2009;26(1):76-84。
{"title":"Assessment of Risk Factors for Coronavirus Disease-2019 in Healthcare Workers: A Case-Control Study.","authors":"Sukhyanti Kerai,&nbsp;Rahil Singh,&nbsp;Kirti N Saxena,&nbsp;Suraj D Desai","doi":"10.5005/jp-journals-10071-24071","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24071","url":null,"abstract":"<p><strong>Background and aims: </strong>With the rise of coronavirus disease-2019 (COVID-19) cases globally, the infection among frontline healthcare workers (HCWs) escalates many folds. There is, however, limited literature from low middle-income countries regarding risk factors for COVID-19 infection in HCWs. We conducted a case-control study to evaluate the risk factors of COVID-19 infection to HCWs.</p><p><strong>Materials and methods: </strong>This case-control study was conducted in a designated COVID-19 hospital. Eighty-one HCWs involved in direct care of COVID-19 patients, identified as cases, and 266 were recruited as controls. Telephonic interviews with participants were conducted, and information regarding demographic variables, chemoprophylaxis, exposure to infected patients, and adherence to infection prevention and control (IPC) measures was collected.</p><p><strong>Results: </strong>We observed a statistically significant difference in the number of times training session for IPC measures attended by HCWs (<i>p</i> = 0.02), performance of aerosol-generating medical procedures (AGMPs) (<i>p</i> <0.001), practices of donning and doffing of personal protective equipment (PPE) (<i>p</i> <0.001), hand hygiene (<i>p</i> <0.001), and decontamination of highly touched surfaces (<i>p</i> <0.001). Logistic regression analysis revealed if the decontamination of highly touched surfaces is decreased by one unit, the odds of getting COVID-19 infection is multiplied by a factor of 0.41 and AGMPs decrease the risk of being a case by 0.76.</p><p><strong>Conclusion: </strong>This study highlighted that inadequate observation of IPC methods increases the risk of COVID-19 infection to frontline HCWs, whereas performance of AGMPs does not enhance the risk. In this study, HCWs undertaking an AGMP, because of concern of acquiring infection, were more diligent during procedures and hence had lesser infection.</p><p><strong>How to cite this article: </strong>Kerai S, Singh R, Saxena KN, Desai SD. Assessment of Risk Factors for Coronavirus Disease-2019 in Healthcare Workers: A Case-Control Study. Indian J Crit Care Med 2022;26(1):76-84.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"76-84"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/bc/ijccm-26-76.PMC8783233.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Peripheral Blood Neutrophil-to-lymphocyte Ratio as a Predictor of Functional Outcomes in Patients with Hemorrhagic Stroke. 外周血中性粒细胞与淋巴细胞比率作为出血性卒中患者功能结局的预测因子。
Sethu Babu, Mathew Pulicken, Arun K Thazhathuveedu

Background: Peripheral blood neutrophil-to-lymphocyte ratio (NLR) has recently emerged as a prognostic biomarker in many disease states. The aim of this study was to evaluate the diagnostic utility of NLR to predict poor functional outcomes in patients with hemorrhagic stroke and to compare it with the intracranial hemorrhage (ICH) score.

Materials and methods: Patients who presented to the emergency department with clinical features suggestive of stroke were evaluated with computed tomography (CT) brain to identify ICH. The ICH scores and NLR were estimated at the time of admission. Modified Rankin Scale (mRS) score equal to or greater than 3 at 90 days was used to define poor functional outcomes (major disability or death). Receiver operating characteristic (ROC) curve was plotted with NLR and the ICH score to analyze and compare their discriminative ability to predict poor functional outcomes.

Results: A total of 158 patients were recruited for the study. One hundred and seven patients were found to have poor functional outcomes as per their mRS score at 90 days. The mean NLR and the ICH scores at presentation were significantly higher for the poor outcome group (6.57 and 2.83) compared to the good outcome group (2.75 and 1.49). The ROC analysis revealed that both NLR and the ICH scores were good predictors of functional outcomes at 90 days with area under the curve (AUC) of 0.814 and 0.819, respectively. The sensitivity and specificity of NLR were 84 and 66.3% and those of the ICH score were 66.7 and 78.3% to predict poor functional outcomes.

Conclusion: In patients with hemorrhagic stroke, NLR at admission is a good predictor of functional outcomes at 90 days. When compared to the ICH score, NLR is more sensitive but less specific in predicting poor functional outcomes.

How to cite this article: Babu S, Pulicken M, Thazhathuveedu AK. Peripheral Blood Neutrophil-to-lymphocyte Ratio as a Predictor of Functional Outcomes in Patients with Hemorrhagic Stroke. Indian J Crit Care Med 2022;26(1):18-22.

背景:外周血中性粒细胞与淋巴细胞比率(NLR)最近已成为许多疾病状态的预后生物标志物。本研究的目的是评估NLR在预测出血性卒中患者功能不良预后方面的诊断效用,并将其与颅内出血(ICH)评分进行比较。材料和方法:向急诊科提出临床特征提示脑卒中的患者用计算机断层扫描(CT)脑评估,以确定脑出血。在入院时评估ICH评分和NLR。采用改良兰金量表(mRS)评分在90天等于或大于3分来定义不良功能结局(主要残疾或死亡)。用NLR和ICH评分绘制受试者工作特征(ROC)曲线,分析比较两者预测功能不良预后的判别能力。结果:研究共招募了158名患者。根据90天mRS评分,107例患者的功能预后较差。预后较差组的NLR和ICH平均评分(6.57和2.83)明显高于预后较好的组(2.75和1.49)。ROC分析显示,NLR和ICH评分均能很好地预测90天的功能结局,曲线下面积(AUC)分别为0.814和0.819。NLR的敏感性和特异性分别为84和66.3%,ICH评分的敏感性和特异性分别为66.7和78.3%。结论:对于出血性卒中患者,入院时NLR是90天功能预后的良好预测指标。与ICH评分相比,NLR在预测功能不良预后方面更敏感,但特异性较低。如何引用本文:Babu S, Pulicken M, Thazhathuveedu AK。外周血中性粒细胞与淋巴细胞比率作为出血性卒中患者功能结局的预测因子。中华检验医学杂志;2016;26(1):18-22。
{"title":"Peripheral Blood Neutrophil-to-lymphocyte Ratio as a Predictor of Functional Outcomes in Patients with Hemorrhagic Stroke.","authors":"Sethu Babu,&nbsp;Mathew Pulicken,&nbsp;Arun K Thazhathuveedu","doi":"10.5005/jp-journals-10071-24074","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24074","url":null,"abstract":"<p><strong>Background: </strong>Peripheral blood neutrophil-to-lymphocyte ratio (NLR) has recently emerged as a prognostic biomarker in many disease states. The aim of this study was to evaluate the diagnostic utility of NLR to predict poor functional outcomes in patients with hemorrhagic stroke and to compare it with the intracranial hemorrhage (ICH) score.</p><p><strong>Materials and methods: </strong>Patients who presented to the emergency department with clinical features suggestive of stroke were evaluated with computed tomography (CT) brain to identify ICH. The ICH scores and NLR were estimated at the time of admission. Modified Rankin Scale (mRS) score equal to or greater than 3 at 90 days was used to define poor functional outcomes (major disability or death). Receiver operating characteristic (ROC) curve was plotted with NLR and the ICH score to analyze and compare their discriminative ability to predict poor functional outcomes.</p><p><strong>Results: </strong>A total of 158 patients were recruited for the study. One hundred and seven patients were found to have poor functional outcomes as per their mRS score at 90 days. The mean NLR and the ICH scores at presentation were significantly higher for the poor outcome group (6.57 and 2.83) compared to the good outcome group (2.75 and 1.49). The ROC analysis revealed that both NLR and the ICH scores were good predictors of functional outcomes at 90 days with area under the curve (AUC) of 0.814 and 0.819, respectively. The sensitivity and specificity of NLR were 84 and 66.3% and those of the ICH score were 66.7 and 78.3% to predict poor functional outcomes.</p><p><strong>Conclusion: </strong>In patients with hemorrhagic stroke, NLR at admission is a good predictor of functional outcomes at 90 days. When compared to the ICH score, NLR is more sensitive but less specific in predicting poor functional outcomes.</p><p><strong>How to cite this article: </strong>Babu S, Pulicken M, Thazhathuveedu AK. Peripheral Blood Neutrophil-to-lymphocyte Ratio as a Predictor of Functional Outcomes in Patients with Hemorrhagic Stroke. Indian J Crit Care Med 2022;26(1):18-22.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"18-22"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/2a/ijccm-26-18.PMC8783256.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39579896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. COSEVAST研究结果:COVID-19严重程度与动脉僵硬度激增成正比的证据。
Neeraj Kumar, Sanjeev Kumar, Abhyuday Kumar, Divendu Bhushan, Amarjeet Kumar, Ajeet Kumar, Veena Singh, Prabhat K Singh

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of arterial walls.

Aims and objective: Our primary objective was to study functional arterial damage in coronavirus disease 2019 (COVID-19) and establish the noninvasive measurement of arterial stiffness as an independent marker of disease severity.

Materials and methods: We recorded the arterial stiffness of 23 mild, 21 moderate, and 20 severe COVID-19 patients grouped on the latest National Institute of Health (NIH) severity criteria. We observed arterial stiffness of COVID-19 patients with standard parameters like noninvasive estimated carotid-femoral pulse wave velocity (cfPWV), age-normalized increase in cfPWV (ANI_cfPWV), age-normalized increase in aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_ AIx). All the parameters were also corrected for statistically significant confounding factors.

Results: Moderate and severe COVID-19 patients have extremely significantly elevated arterial stiffness than mild patients. In mild patients, cfPWV (829.1 ± 139.2 cm/second) was significantly lower than both moderate (1067 ± 152.5 cm/second, p <0.0001) and severe (1416 ± 253.9 cm/second, p <0.0001) patients. ANI_cfPWV in moderate and severe patients was significantly higher than mild patients (mild: 101.2 ± 126.1 cm/second; moderate: 279 ± 114.4 cm/second; severe: 580.1 ± 216.4 cm/second; intergroup p <0.0001). The results even after correction for significant confounding factors did not show any considerable change in the increasing trend of arterial stiffness.

Conclusion: This study establishes the functional deterioration of arteries in proportion to the severity of COVID-19.

How to cite this article: Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, et al. The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. Indian J Crit Care Med 2021;25(10):1113-1119.

背景:严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染对心血管系统的影响是多方面的。它最初感染内皮细胞,引起明显的内皮损伤和炎症。然而,没有经验证据表明动脉壁功能受损。目的和目的:我们的主要目的是研究冠状病毒病2019 (COVID-19)的功能性动脉损伤,并建立动脉硬度的无创测量作为疾病严重程度的独立标志。材料和方法:我们记录了23例轻度、21例中度和20例重度COVID-19患者的动脉僵硬度,这些患者按照美国国立卫生研究院(NIH)最新的严重程度标准分组。我们用无创估计颈-股脉波速度(cfPWV)、cfPWV的年龄归一化升高(ANI_cfPWV)、主动脉增压压(ANI_AugP)的年龄归一化升高、心率归一化增强指数(HRN_ AIx)等标准参数观察COVID-19患者的动脉硬度。所有参数也对统计上显著的混杂因素进行了校正。结果:中、重度COVID-19患者动脉僵硬度明显高于轻度患者。在轻度患者中,cfPWV(829.1±139.2 cm/s)显著低于中度患者(1067±152.5 cm/s), p p p p。结论:本研究确定了动脉功能恶化与COVID-19严重程度成比例。如何引用本文:Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A,等。COSEVAST研究结果:COVID-19严重程度与动脉僵硬度激增成正比的证据。中华检验医学杂志;2011;25(10):1113-1119。
{"title":"The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness.","authors":"Neeraj Kumar,&nbsp;Sanjeev Kumar,&nbsp;Abhyuday Kumar,&nbsp;Divendu Bhushan,&nbsp;Amarjeet Kumar,&nbsp;Ajeet Kumar,&nbsp;Veena Singh,&nbsp;Prabhat K Singh","doi":"10.5005/jp-journals-10071-24000","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24000","url":null,"abstract":"<p><strong>Background: </strong>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of arterial walls.</p><p><strong>Aims and objective: </strong>Our primary objective was to study functional arterial damage in coronavirus disease 2019 (COVID-19) and establish the noninvasive measurement of arterial stiffness as an independent marker of disease severity.</p><p><strong>Materials and methods: </strong>We recorded the arterial stiffness of 23 mild, 21 moderate, and 20 severe COVID-19 patients grouped on the latest National Institute of Health (NIH) severity criteria. We observed arterial stiffness of COVID-19 patients with standard parameters like noninvasive estimated carotid-femoral pulse wave velocity (cfPWV), age-normalized increase in cfPWV (ANI_cfPWV), age-normalized increase in aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_ AIx). All the parameters were also corrected for statistically significant confounding factors.</p><p><strong>Results: </strong>Moderate and severe COVID-19 patients have extremely significantly elevated arterial stiffness than mild patients. In mild patients, cfPWV (829.1 ± 139.2 cm/second) was significantly lower than both moderate (1067 ± 152.5 cm/second, <i>p</i> <0.0001) and severe (1416 ± 253.9 cm/second, <i>p</i> <0.0001) patients. ANI_cfPWV in moderate and severe patients was significantly higher than mild patients (mild: 101.2 ± 126.1 cm/second; moderate: 279 ± 114.4 cm/second; severe: 580.1 ± 216.4 cm/second; intergroup <i>p</i> <0.0001). The results even after correction for significant confounding factors did not show any considerable change in the increasing trend of arterial stiffness.</p><p><strong>Conclusion: </strong>This study establishes the functional deterioration of arteries in proportion to the severity of COVID-19.</p><p><strong>How to cite this article: </strong>Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, <i>et al.</i> The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. Indian J Crit Care Med 2021;25(10):1113-1119.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1113-1119"},"PeriodicalIF":2.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/1b/ijccm-25-1113.PMC8645816.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39821267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission. 印度COVID-19重症患者直接医疗成本分析
Kamini N Reddy, Jignesh Shah, Shivakumar Iyer, Monidipa Chowdhury, Naveen Yerrapalem, Neeraja Pasalkar, Prashant P Jedge

Introduction: Intensive care unit (ICU) admission is required for approximately 25% of patients affected with coronavirus disease-19 (COVID-19) and imposes a high economic burden on patients in resource-limited settings.

Method: We conducted a retrospective direct medical care cost analysis of COVID-19 patients requiring ICU admission after obtaining the Institutional Ethics Committee approval. Data were obtained from the records of patients admitted to the COVID-19 ICU of a tertiary care trust teaching hospital from June 2020 to December 2020. Direct costs were analyzed and correlated with various demographic variables and clinical outcomes.

Results: A total of 176 patients were included (males-76%). The median direct medical cost for a median stay of 13 days was INR 202248.5 ($ 2742.91). Hospital drugs and disposables accounted for 20% of the total cost followed by bed charges (19%), equipment charges (17%), biosafety protective gear (15.5%), pathological and radiological tests (15%), clinical management (7.6%), and biomedical waste management (1.6%). Government schemes accounted for 79% of medical claims followed by directly paying patients (12.5%) and private insurance (8.5%). The cost was significantly higher in patients with diabetes mellitus and sepsis and in those requiring mechanical ventilation (MV) (p <0.05). Shorter lead time to hospital admission and lesser length of hospital stay were associated with significant lower direct cost.

Conclusion: Direct medical care cost is substantial for COVID-19 patients requiring ICU admission. This cost is significantly associated with increased ICU and hospital stay, longer lead time to admission, diabetes mellitus, sepsis, and those who need high-flow nasal cannula (HFNC), noninvasive ventilation (NIV), and MV.

How to cite this article: Reddy KN, Shah J, Iyer S, Chowdhury M, Yerrapalem N, Pasalkar N, et al. Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission. Indian J Crit Care Med 2021;25(10):1120-1125.

大约25%的冠状病毒病-19 (COVID-19)患者需要入住重症监护病房(ICU),在资源有限的环境中,这给患者带来了沉重的经济负担。方法:在获得机构伦理委员会批准后,对需要ICU住院的COVID-19患者进行回顾性直接医疗成本分析。数据来自某三级医疗信托教学医院2020年6月至2020年12月COVID-19重症监护室收治的患者记录。对直接成本进行分析,并将其与各种人口统计学变量和临床结果相关联。结果:共纳入176例患者(男性76%)。住院13天的直接医疗费用中位数为202248.5印度卢比(2742.91美元)。医院药品和一次性用品占总费用的20%,其次是床位费(19%)、设备费(17%)、生物安全防护装备(15.5%)、病理和放射检查(15%)、临床管理(7.6%)和生物医学废物管理(1.6%)。政府计划占医疗索赔的79%,其次是直接支付病人(12.5%)和私人保险(8.5%)。糖尿病和脓毒症患者以及需要机械通气(MV)的患者的直接医疗费用明显高于其他患者(p)。该费用与ICU和住院时间增加、入院前时间延长、糖尿病、败血症以及需要高流量鼻插管(HFNC)、无创通气(NIV)和MV的患者显著相关。本文摘自:Reddy KN, Shah J, Iyer S, Chowdhury M, Yerrapalem N, Pasalkar N,等。印度COVID-19重症患者直接医疗成本分析中华检验医学杂志;2011;25(10):1120-1125。
{"title":"Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission.","authors":"Kamini N Reddy,&nbsp;Jignesh Shah,&nbsp;Shivakumar Iyer,&nbsp;Monidipa Chowdhury,&nbsp;Naveen Yerrapalem,&nbsp;Neeraja Pasalkar,&nbsp;Prashant P Jedge","doi":"10.5005/jp-journals-10071-23991","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-23991","url":null,"abstract":"<p><strong>Introduction: </strong>Intensive care unit (ICU) admission is required for approximately 25% of patients affected with coronavirus disease-19 (COVID-19) and imposes a high economic burden on patients in resource-limited settings.</p><p><strong>Method: </strong>We conducted a retrospective direct medical care cost analysis of COVID-19 patients requiring ICU admission after obtaining the Institutional Ethics Committee approval. Data were obtained from the records of patients admitted to the COVID-19 ICU of a tertiary care trust teaching hospital from June 2020 to December 2020. Direct costs were analyzed and correlated with various demographic variables and clinical outcomes.</p><p><strong>Results: </strong>A total of 176 patients were included (males-76%). The median direct medical cost for a median stay of 13 days was INR 202248.5 ($ 2742.91). Hospital drugs and disposables accounted for 20% of the total cost followed by bed charges (19%), equipment charges (17%), biosafety protective gear (15.5%), pathological and radiological tests (15%), clinical management (7.6%), and biomedical waste management (1.6%). Government schemes accounted for 79% of medical claims followed by directly paying patients (12.5%) and private insurance (8.5%). The cost was significantly higher in patients with diabetes mellitus and sepsis and in those requiring mechanical ventilation (MV) (<i>p</i> <0.05). Shorter lead time to hospital admission and lesser length of hospital stay were associated with significant lower direct cost.</p><p><strong>Conclusion: </strong>Direct medical care cost is substantial for COVID-19 patients requiring ICU admission. This cost is significantly associated with increased ICU and hospital stay, longer lead time to admission, diabetes mellitus, sepsis, and those who need high-flow nasal cannula (HFNC), noninvasive ventilation (NIV), and MV.</p><p><strong>How to cite this article: </strong>Reddy KN, Shah J, Iyer S, Chowdhury M, Yerrapalem N, Pasalkar N, <i>et al</i>. Direct Medical Cost Analysis of Indian COVID-19 Patients Requiring Critical Care Admission. Indian J Crit Care Med 2021;25(10):1120-1125.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1120-1125"},"PeriodicalIF":2.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/88/ijccm-25-1120.PMC8645812.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39821268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in those with Pulmonary Embolism in the Course of Coronavirus Disease 2019. 2019冠状病毒病过程中肺栓塞患者中性粒细胞与淋巴细胞和血小板与淋巴细胞比值的研究
Canan Akkus, Hakan Yilmaz, Rahime Duran, Suleyman Diker, Semih Celik, Cevdet Duran

Background: To investigate the levels of neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios in those having a pulmonary embolism (PE) in the course of coronavirus disease 2019 (COVID-19).

Methods: The records of those having COVID-19 were retrospectively obtained from the hospital automation system. NLR and PLR were measured with the help of patients' blood cell counts.

Results: Of 1,452 COVID-19 patients, 17 (1.2%) were diagnosed with PE. Compared with the controls, while leukocyte (p = 0.001), neutrophil (p <0.001), and neutrophil percentages, (p = 0.001) and NLR (p <0.001) and PLR (p = 0.006) had higher values, lymphocyte count (p = 0.004) and lymphocyte percentage (p <0.001) showed lower values in the patients with PE.Compared to the survivors, the non-survivors were found to have increased leukocyte (p <0.001), neutrophil (p <0.001), and neutrophil percentages (p <0.001), NLR (p <0.001) and PLR (p <0.001), and decreased lymphocyte (p <0.001) counts and percentage (p <0.001), hemoglobin (p = 0.005), hematocrit (p = 0.012), and platelet counts (p <0.001).While NLR and PLR cutoffs were found as 4.338 and 187.83 in predicting PE, the cutoff values of NLR and PLR were, respectively, 4.301 and 172.5 in predicting mortality.The logistic regression analysis also revealed that all hematological parameters had no effects on the development of PE.

Conclusion: Although NLR and PLR had higher scores in PE patients, no relationship was determined between the levels of NLR and PLR and PE development. Further prospective studies including larger populations are required to enlighten the increased NLR and PLR in PE patients having COVID-19.

How to cite this article: Akkus C, Yilmaz H, Duran R, Diker S, Celik S, Duran C. Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in those with Pulmonary Embolism in the Course of Coronavirus Disease 2019. Indian J Crit Care Med 2021;25(10):1133-1136.

背景:探讨2019冠状病毒病(COVID-19)期间肺栓塞(PE)患者中性粒细胞与淋巴细胞(NLR)和血小板与淋巴细胞(PLR)比值的水平。方法:从医院自动化系统中回顾性获取COVID-19患者的病历。NLR和PLR在患者血细胞计数的帮助下测定。结果:1452例COVID-19患者中,17例(1.2%)被诊断为PE。与对照组相比,白细胞(p = 0.001)、中性粒细胞(p = 0.001)、NLR (p = 0.006)、淋巴细胞计数(p = 0.004)、淋巴细胞百分比(p p p p p p p p p p p p p p p p p p)、红细胞压积(p = 0.012)、血小板计数(p)均高于对照组。结论:PE患者NLR和PLR评分较高,但NLR和PLR水平与PE发展无关系。需要进一步的前瞻性研究,包括更大的人群,来揭示COVID-19 PE患者NLR和PLR的增加。Akkus C, Yilmaz H, Duran R, Diker S, Celik S, Duran C. 2019冠状病毒病肺栓塞患者中性粒细胞与淋巴细胞比值的研究。中华检验医学杂志;2009;25(10):1133-1136。
{"title":"Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in those with Pulmonary Embolism in the Course of Coronavirus Disease 2019.","authors":"Canan Akkus,&nbsp;Hakan Yilmaz,&nbsp;Rahime Duran,&nbsp;Suleyman Diker,&nbsp;Semih Celik,&nbsp;Cevdet Duran","doi":"10.5005/jp-journals-10071-23998","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-23998","url":null,"abstract":"<p><strong>Background: </strong>To investigate the levels of neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios in those having a pulmonary embolism (PE) in the course of coronavirus disease 2019 (COVID-19).</p><p><strong>Methods: </strong>The records of those having COVID-19 were retrospectively obtained from the hospital automation system. NLR and PLR were measured with the help of patients' blood cell counts.</p><p><strong>Results: </strong>Of 1,452 COVID-19 patients, 17 (1.2%) were diagnosed with PE. Compared with the controls, while leukocyte (<i>p</i> = 0.001), neutrophil (<i>p</i> <0.001), and neutrophil percentages, (<i>p</i> = 0.001) and NLR (<i>p</i> <0.001) and PLR (<i>p</i> = 0.006) had higher values, lymphocyte count (<i>p</i> = 0.004) and lymphocyte percentage (<i>p</i> <0.001) showed lower values in the patients with PE.Compared to the survivors, the non-survivors were found to have increased leukocyte (<i>p</i> <0.001), neutrophil (<i>p</i> <0.001), and neutrophil percentages (<i>p</i> <0.001), NLR (<i>p</i> <0.001) and PLR (<i>p</i> <0.001), and decreased lymphocyte (<i>p</i> <0.001) counts and percentage (<i>p</i> <0.001), hemoglobin (<i>p</i> = 0.005), hematocrit (<i>p</i> = 0.012), and platelet counts (<i>p</i> <0.001).While NLR and PLR cutoffs were found as 4.338 and 187.83 in predicting PE, the cutoff values of NLR and PLR were, respectively, 4.301 and 172.5 in predicting mortality.The logistic regression analysis also revealed that all hematological parameters had no effects on the development of PE.</p><p><strong>Conclusion: </strong>Although NLR and PLR had higher scores in PE patients, no relationship was determined between the levels of NLR and PLR and PE development. Further prospective studies including larger populations are required to enlighten the increased NLR and PLR in PE patients having COVID-19.</p><p><strong>How to cite this article: </strong>Akkus C, Yilmaz H, Duran R, Diker S, Celik S, Duran C. Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in those with Pulmonary Embolism in the Course of Coronavirus Disease 2019. Indian J Crit Care Med 2021;25(10):1133-1136.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1133-1136"},"PeriodicalIF":2.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/63/f7/ijccm-25-1133.PMC8645821.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39821270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients. 甲状腺功能、逆转三碘甲状腺原氨酸与危重症患者死亡率。
Carlos Dg da Silveira, Flávio Pj de Vasconcelos, Edmilson B Moura, Bruno Tg da Silveira, Flávio Fp Amorim, Lumie S Shintaku, Rosália B de Santana, Pedro Lp Argotte, Sheila F da Silva, Marcelo de Oliveira Maia, Fabio F Amorim

Background: To evaluate the association of thyroid hormones changes, including increased reverse triiodothyronine (rT3) level, with critically ill clinical patients´ mortality.

Patients and methods: This study analyzed the observational data prospectively collected over 8 months (2018) in an adult intensive care unit (ICU) in Brasilia, Brazil. All consecutive ICU-admitted clinical patients were included. Thyroxine (T4), free thyroxine (fT4), triiodothyronine (T3), free triiodothyronine (fT3), rT3, and thyroid-stimulating hormone (TSH) were collected within 48 hours of ICU admission. Patients with hypothyroidism or hyperthyroidism who were previously diagnosed were excluded.

Results: Of 353 included patients, age was 68.5 ± 19.0 years, sequential organ failure assessment (SOFA) score was 3.3 ± 2.9, and Acute Physiology and Chronic Health Evaluation II (APACHE II) was 17.1 ± 7.9. ICU mortality was 17.6% (n = 62). Non-survivor patients had a higher incidence of increased rT3 (69.3 vs 59.2%, p = 0.042), lower incidence of low T4 (4.8 vs 9.7%, p = 0.045), and increased age (75.2 ± 16.3 years vs 67.1 ± 19.3 years, p = 0.001), SOFA (3.0 ± 0.4 vs 2.8 ± 2.6, p <0.001), and APACHE II (23.5 ± 7.5 vs 15.7 ± 7.2, p <0.001). Alterations in other thyroid hormones did not show association with mortality. Increased rT3 [odds ratio (OR): 2.436; 95% confidence interval (CI): 1.023-5.800; p = 0.020] and APACHE II (OR: 1.083, 95% CI: 1.012-1.158; p = 0.044) were associated with ICU mortality in the multivariate analysis.

Conclusion: Increased rT3 was independently associated with increased ICU mortality. In contrast, other thyroid hormone alterations did not show an association with mortality. Determining rT3 levels may be a helpful test to identify an increased risk for ICU mortality in clinical patients.

How to cite this article: da Silveira CDG, de Vasconcelos FPJ, Moura EB, da Silveira BTG, Amorim FFP, Shintaku LS, et al. Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients. Indian J Crit Care Med 2021;25(10):1161-1166.

背景:评估甲状腺激素变化,包括逆转三碘甲状腺原氨酸(rT3)水平升高与危重症临床患者死亡率的关系。患者和方法:本研究分析了巴西巴西利亚成人重症监护病房(ICU) 8个月(2018年)的前瞻性观察数据。纳入所有连续icu住院的临床患者。入院48小时内采集甲状腺素(T4)、游离甲状腺素(fT4)、三碘甲状腺原氨酸(T3)、游离三碘甲状腺原氨酸(fT3)、rT3、促甲状腺激素(TSH)。排除既往诊断为甲状腺功能减退或甲状腺功能亢进的患者。结果:353例患者的年龄为68.5±19.0岁,顺序器官衰竭评分(SOFA)为3.3±2.9分,急性生理和慢性健康评估II (APACHE II)为17.1±7.9分。ICU死亡率为17.6% (n = 62)。非存活患者的rT3升高发生率较高(69.3 vs 59.2%, p = 0.042),低T4发生率较低(4.8 vs 9.7%, p = 0.045),年龄增加(75.2±16.3岁vs 67.1±19.3岁,p = 0.001), SOFA(3.0±0.4 vs 2.8±2.6,p = 0.020)和APACHE II (OR: 1.083, 95% CI: 1.012-1.158;p = 0.044)与ICU死亡率相关。结论:rT3升高与ICU死亡率升高独立相关。相比之下,其他甲状腺激素的改变与死亡率没有关联。测定rT3水平可能有助于鉴别临床患者ICU死亡风险的增加。如何引用本文:da Silveira CDG, de Vasconcelos FPJ, Moura EB, da Silveira BTG, Amorim FFP, Shintaku LS等。甲状腺功能、逆转三碘甲状腺原氨酸与危重症患者死亡率。中华检验医学杂志;2009;25(10):1161-1166。
{"title":"Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients.","authors":"Carlos Dg da Silveira,&nbsp;Flávio Pj de Vasconcelos,&nbsp;Edmilson B Moura,&nbsp;Bruno Tg da Silveira,&nbsp;Flávio Fp Amorim,&nbsp;Lumie S Shintaku,&nbsp;Rosália B de Santana,&nbsp;Pedro Lp Argotte,&nbsp;Sheila F da Silva,&nbsp;Marcelo de Oliveira Maia,&nbsp;Fabio F Amorim","doi":"10.5005/jp-journals-10071-24001","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24001","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the association of thyroid hormones changes, including increased reverse triiodothyronine (rT3) level, with critically ill clinical patients´ mortality.</p><p><strong>Patients and methods: </strong>This study analyzed the observational data prospectively collected over 8 months (2018) in an adult intensive care unit (ICU) in Brasilia, Brazil. All consecutive ICU-admitted clinical patients were included. Thyroxine (T4), free thyroxine (fT4), triiodothyronine (T3), free triiodothyronine (fT3), rT3, and thyroid-stimulating hormone (TSH) were collected within 48 hours of ICU admission. Patients with hypothyroidism or hyperthyroidism who were previously diagnosed were excluded.</p><p><strong>Results: </strong>Of 353 included patients, age was 68.5 ± 19.0 years, sequential organ failure assessment (SOFA) score was 3.3 ± 2.9, and Acute Physiology and Chronic Health Evaluation II (APACHE II) was 17.1 ± 7.9. ICU mortality was 17.6% (<i>n</i> = 62). Non-survivor patients had a higher incidence of increased rT3 (69.3 vs 59.2%, <i>p</i> = 0.042), lower incidence of low T4 (4.8 vs 9.7%, <i>p</i> = 0.045), and increased age (75.2 ± 16.3 years vs 67.1 ± 19.3 years, <i>p</i> = 0.001), SOFA (3.0 ± 0.4 vs 2.8 ± 2.6, <i>p</i> <0.001), and APACHE II (23.5 ± 7.5 vs 15.7 ± 7.2, <i>p</i> <0.001). Alterations in other thyroid hormones did not show association with mortality. Increased rT3 [odds ratio (OR): 2.436; 95% confidence interval (CI): 1.023-5.800; <i>p</i> = 0.020] and APACHE II (OR: 1.083, 95% CI: 1.012-1.158; <i>p</i> = 0.044) were associated with ICU mortality in the multivariate analysis.</p><p><strong>Conclusion: </strong>Increased rT3 was independently associated with increased ICU mortality. In contrast, other thyroid hormone alterations did not show an association with mortality. Determining rT3 levels may be a helpful test to identify an increased risk for ICU mortality in clinical patients.</p><p><strong>How to cite this article: </strong>da Silveira CDG, de Vasconcelos FPJ, Moura EB, da Silveira BTG, Amorim FFP, Shintaku LS, <i>et al.</i> Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients. Indian J Crit Care Med 2021;25(10):1161-1166.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1161-1166"},"PeriodicalIF":2.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/97/ef/ijccm-25-1161.PMC8645806.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39732337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Aftermath of COVID-19 and Critical Care in India. 2019冠状病毒病的后果和印度的重症监护。
Rajesh Panda, Divya Hirolli, Dalim K Baidya

The coronavirus disease-2019 (COVID-19) pandemic had overwhelmed the healthcare system and forced many patients to be treated at home with oxygen, antibiotics, and steroids, particularly during the second wave. There was increased misuse of antimicrobials in hospitals as well as unguarded self-prescription of these medications among the common people. We are likely to see an increase in the incidence of antimicrobial resistance (AMR), change in the susceptibility pattern of the organisms causing community-acquired infections, and an increase in opportunistic bacterial, tubercular, viral, and fungal infections. How to cite this article: Panda R, Hirolli D, Baidya DK. Aftermath of COVID-19 and Critical Care in India. Indian J Crit Care Med 2021; 25(10):1173-1175.

冠状病毒病-2019 (COVID-19)大流行使医疗保健系统不堪重负,迫使许多患者在家中接受氧气、抗生素和类固醇治疗,特别是在第二波疫情期间。医院滥用抗微生物药物的情况有所增加,普通民众在没有保护的情况下自行处方这些药物。我们可能会看到抗菌素耐药性(AMR)发生率的增加,引起社区获得性感染的生物体的敏感性模式的变化,以及机会性细菌、结核、病毒和真菌感染的增加。如何引用本文:Panda R, Hirolli D, Baidya DK。2019冠状病毒病的后果和印度的重症监护。印度急救医学杂志2021;25(10): 1173 - 1175。
{"title":"Aftermath of COVID-19 and Critical Care in India.","authors":"Rajesh Panda,&nbsp;Divya Hirolli,&nbsp;Dalim K Baidya","doi":"10.5005/jp-journals-10071-23987","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-23987","url":null,"abstract":"<p><p>The coronavirus disease-2019 (COVID-19) pandemic had overwhelmed the healthcare system and forced many patients to be treated at home with oxygen, antibiotics, and steroids, particularly during the second wave. There was increased misuse of antimicrobials in hospitals as well as unguarded self-prescription of these medications among the common people. We are likely to see an increase in the incidence of antimicrobial resistance (AMR), change in the susceptibility pattern of the organisms causing community-acquired infections, and an increase in opportunistic bacterial, tubercular, viral, and fungal infections. <b>How to cite this article:</b> Panda R, Hirolli D, Baidya DK. Aftermath of COVID-19 and Critical Care in India. Indian J Crit Care Med 2021; 25(10):1173-1175.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1173-1175"},"PeriodicalIF":2.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/70/ijccm-25-1173.PMC8645805.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39732339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1